Arcus Biosciences (RCUS) Stock News
$RCUS · NYSE · HEALTHCARE · 5 stories in 30 days$18.50
1D −3.07%1W +5.51%1M −8.48%
BORSA has published 5 stories on Arcus Biosciences (RCUS) in the past 30 days. BORSA’s news read on RCUS is mixed at 46/100, based on 5 company events over the past 7 days. RCUS last closed at $23.75 on Oct 20, up 5.51% over five sessions and down 8.48% over the past month. Arcus Biosciences’ next earnings report is scheduled for Tuesday, Oct 27.
The wire on $RCUS
newest first · updated · direct subject stories onlyKuehn Law investigates Arcus Biosciences for potential fiduciary breaches
Shareholder litigation firm Kuehn Law is investigating whether Arcus Biosciences officers and directors breached fiduciary duties through potential self-dealing. Long-term shareholders may be entitled to damages and governance reforms.
bearish 35 · impact 30Arcus Biosciences down over 13%, on track for largest percent drop since December 2025
RCUS fell 13.16% to $20.62, lowest since March 2026. Largest percent decline since Dec. 12, 2025. No catalyst cited.
· impact 60